Literature DB >> 25877204

Cancer: A most exceptional response.

Vivien Marx.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25877204     DOI: 10.1038/520389a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Persistence of dual-tropic HIV-1 in an individual homozygous for the CCR5 Delta 32 allele.

Authors:  Paul R Gorry; Chengsheng Zhang; Sam Wu; Kevin Kunstman; Elizabeth Trachtenberg; John Phair; Steven Wolinsky; Dana Gabuzda
Journal:  Lancet       Date:  2002-05-25       Impact factor: 79.321

2.  Translational genomics. Clues from the resilient.

Authors:  Stephen H Friend; Eric E Schadt
Journal:  Science       Date:  2014-05-30       Impact factor: 47.728

3.  Response and acquired resistance to everolimus in anaplastic thyroid cancer.

Authors:  Nikhil Wagle; Brian C Grabiner; Eliezer M Van Allen; Ali Amin-Mansour; Amaro Taylor-Weiner; Mara Rosenberg; Nathanael Gray; Justine A Barletta; Yanan Guo; Scott J Swanson; Daniel T Ruan; Glenn J Hanna; Robert I Haddad; Gad Getz; David J Kwiatkowski; Scott L Carter; David M Sabatini; Pasi A Jänne; Levi A Garraway; Jochen H Lorch
Journal:  N Engl J Med       Date:  2014-10-09       Impact factor: 91.245

4.  Genome sequencing identifies a basis for everolimus sensitivity.

Authors:  Gopa Iyer; Aphrothiti J Hanrahan; Matthew I Milowsky; Hikmat Al-Ahmadie; Sasinya N Scott; Manickam Janakiraman; Mono Pirun; Chris Sander; Nicholas D Socci; Irina Ostrovnaya; Agnes Viale; Adriana Heguy; Luke Peng; Timothy A Chan; Bernard Bochner; Dean F Bajorin; Michael F Berger; Barry S Taylor; David B Solit
Journal:  Science       Date:  2012-08-23       Impact factor: 47.728

5.  Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.

Authors:  Garrett M Frampton; Alex Fichtenholtz; Geoff A Otto; Kai Wang; Sean R Downing; Jie He; Michael Schnall-Levin; Jared White; Eric M Sanford; Peter An; James Sun; Frank Juhn; Kristina Brennan; Kiel Iwanik; Ashley Maillet; Jamie Buell; Emily White; Mandy Zhao; Sohail Balasubramanian; Selmira Terzic; Tina Richards; Vera Banning; Lazaro Garcia; Kristen Mahoney; Zac Zwirko; Amy Donahue; Himisha Beltran; Juan Miguel Mosquera; Mark A Rubin; Snjezana Dogan; Cyrus V Hedvat; Michael F Berger; Lajos Pusztai; Matthias Lechner; Chris Boshoff; Mirna Jarosz; Christine Vietz; Alex Parker; Vincent A Miller; Jeffrey S Ross; John Curran; Maureen T Cronin; Philip J Stephens; Doron Lipson; Roman Yelensky
Journal:  Nat Biotechnol       Date:  2013-10-20       Impact factor: 54.908

6.  A community effort to assess and improve drug sensitivity prediction algorithms.

Authors:  James C Costello; Laura M Heiser; Elisabeth Georgii; Mehmet Gönen; Michael P Menden; Nicholas J Wang; Mukesh Bansal; Muhammad Ammad-ud-din; Petteri Hintsanen; Suleiman A Khan; John-Patrick Mpindi; Olli Kallioniemi; Antti Honkela; Tero Aittokallio; Krister Wennerberg; James J Collins; Dan Gallahan; Dinah Singer; Julio Saez-Rodriguez; Samuel Kaski; Joe W Gray; Gustavo Stolovitzky
Journal:  Nat Biotechnol       Date:  2014-06-01       Impact factor: 54.908

  6 in total
  8 in total

1.  Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype.

Authors:  Timothy N Phoenix; Deanna M Patmore; Scott Boop; Nidal Boulos; Megan O Jacus; Yogesh T Patel; Martine F Roussel; David Finkelstein; Liliana Goumnerova; Sebastien Perreault; Elizabeth Wadhwa; Yoon-Jae Cho; Clinton F Stewart; Richard J Gilbertson
Journal:  Cancer Cell       Date:  2016-03-31       Impact factor: 31.743

2.  Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers.

Authors:  Xiaojing Liu; Iris L Romero; Lacey M Litchfield; Ernst Lengyel; Jason W Locasale
Journal:  Cell Metab       Date:  2016-10-13       Impact factor: 27.287

Review 3.  Personal Mutanomes Meet Modern Oncology Drug Discovery and Precision Health.

Authors:  Feixiong Cheng; Han Liang; Atul J Butte; Charis Eng; Ruth Nussinov
Journal:  Pharmacol Rev       Date:  2018-12-13       Impact factor: 25.468

Review 4.  Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer.

Authors:  David D Bowtell; Steffen Böhm; Ahmed A Ahmed; Paul-Joseph Aspuria; Robert C Bast; Valerie Beral; Jonathan S Berek; Michael J Birrer; Sarah Blagden; Michael A Bookman; James D Brenton; Katherine B Chiappinelli; Filipe Correia Martins; George Coukos; Ronny Drapkin; Richard Edmondson; Christina Fotopoulou; Hani Gabra; Jérôme Galon; Charlie Gourley; Valerie Heong; David G Huntsman; Marcin Iwanicki; Beth Y Karlan; Allyson Kaye; Ernst Lengyel; Douglas A Levine; Karen H Lu; Iain A McNeish; Usha Menon; Steven A Narod; Brad H Nelson; Kenneth P Nephew; Paul Pharoah; Daniel J Powell; Pilar Ramos; Iris L Romero; Clare L Scott; Anil K Sood; Euan A Stronach; Frances R Balkwill
Journal:  Nat Rev Cancer       Date:  2015-11       Impact factor: 60.716

5.  Clinical response to everolimus in a patient with Hodgkin's lymphoma harboring a TSC2 mutation.

Authors:  G F Perini; P V Campregher; J S Ross; S Ali; N Hamerschlak; F P S Santos
Journal:  Blood Cancer J       Date:  2016-05-13       Impact factor: 11.037

Review 6.  Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine.

Authors:  Krysta Mila Coyle; Jeanette E Boudreau; Paola Marcato
Journal:  Biomed Res Int       Date:  2017-06-08       Impact factor: 3.411

7.  A link prediction approach to cancer drug sensitivity prediction.

Authors:  Turki Turki; Zhi Wei
Journal:  BMC Syst Biol       Date:  2017-10-03

8.  Investigating skewness to understand gene expression heterogeneity in large patient cohorts.

Authors:  Benjamin V Church; Henry T Williams; Jessica C Mar
Journal:  BMC Bioinformatics       Date:  2019-12-20       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.